TRAM Snapshot of App at Pub for Oppostn

COFIX RX

CoFix-RX, LLC

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 90337951 FILING DATE 11/23/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY LOOK, JEFFREY J
L.O. ASSIGNED O30-NOT FOUND

PUB INFORMATION

RUN DATE 04/23/2022
PUB DATE N/A
STATUS 680-APPROVED FOR PUBLICATION
STATUS DATE 04/22/2022
LITERAL MARK ELEMENT COFIX RX

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT COFIX RX
MARK DRAWING CODE 5-AN ILLUSTRATION DRAWING WITH WORD(S)/LETTER(S)/NUMBER(S) IN STYLIZED FORM
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME CoFix-RX, LLC
ADDRESS 40900 Woodward Avenue Suite 111
Bloomfield Hills, MI 48304
ENTITY 16-LTD LIAB CO
CITIZENSHIP Michigan

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations and substances, used internally as pills and other solids, and also used as sprays and liquids for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; Pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; All-purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Nasal spray for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, spores
INTERNATIONAL CLASS 011
          DESCRIPTION TEXT Disinfectant apparatus for medical purposes; Disinfectant apparatus for medical purposes for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Cleansing/sanitizing system comprising a containment enclosure specially adapted for containing an atomized cleansing/sanitizing spray mechanism for use in the cleansing/sanitizing of objects including articles of manufacture, natural products, foods and pharmaceuticals

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 011 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
COLORS CLAIMED STATEMENT The color(s) red, black and white is/are claimed as a feature of the mark.
DESCRIPTION OF MARK The mark consists of the letter "CO" in large capital letters shaded in red and outlined in black followed by the word "Fix" in white and outlined in black with the letters "RX" dropped after the letter "x" in "Fix" with the letter "R" in red and a portion of the letter "X" in white both of which are outlined in black.
PSEUDO MARK CO FIX RX

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
04/22/2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 016
04/06/2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 015
04/06/2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 014
04/06/2022 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED 013
10/08/2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED 012
10/08/2021 GNFR O FINAL REFUSAL E-MAILED 011
10/08/2021 CNFR R FINAL REFUSAL WRITTEN 010
09/09/2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 009
09/09/2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 008
09/09/2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
04/14/2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
04/14/2021 GNRT F NON-FINAL ACTION E-MAILED 005
04/14/2021 CNRT R NON-FINAL ACTION WRITTEN 004
04/13/2021 DOCK D ASSIGNED TO EXAMINER 003
01/28/2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
11/26/2020 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Michael G. Shariff
CORRESPONDENCE ADDRESS Michael G. Shariff
INVENTA CAPITAL PLC
40900 WOODWARD AVENUE SUITE 111
BLOOMFIELD HILLS MI 48304
DOMESTIC REPRESENTATIVE NONE

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed